X Li, C Liu, Z Mao, Q Li, S Qi… - Journal of Clinical …, 2021 - Wiley Online Library
What is known and objective Gram‐negative bacteremia remains a major health problem around the world. The optimal duration of antibiotic treatment has been poorly defined, and …
M Bae, Y Jeong, S Bae, MJ Kim… - Journal of …, 2022 - academic.oup.com
Background The optimal duration of antimicrobial therapy for uncomplicated Pseudomonas aeruginosa bloodstream infection (BSI) is unknown. We compared the outcomes of short …
Carbapenem-resistant Acinetobacter baumannii (CRAB) is one of the most commonly reported nosocomial infections in cancer patients and could be fatal because of suboptimal …
CC Lee, CH Lee, PL Chen, CC Hsieh, HJ Tang, WC Ko - Antibiotics, 2019 - mdpi.com
Cefazolin is traditionally active against Escherichia coli, Klebsiella species, and Proteus mirabilis (EKP) isolates. The Clinical and Laboratory Standards Institute (CLSI) has twice …
CC Lee, PL Chen, CC Hsieh, CY Yang, CH Lin, WC Ko - Antibiotics, 2020 - mdpi.com
To compare prognoses and adverse events between bacteraemic patients in the emergency department (ED) who received an early antimicrobial IV-to-PO switch and those treated with …
CY Ho, CH Lee, CY Yang, CC Hsieh, WC Ko… - Journal of Infection and …, 2020 - Elsevier
To study whether antimicrobial escalation is beneficial for the outcome of bacteremia patients receiving appropriate but less responsive antimicrobials as empirical therapy …
Y Li, J Yang, H Yang, J Guo, D Zhang - 2020 - researchsquare.com
Objectives: The optimal duration of therapy for primary bloodstream infection (BSI) and BSI secondary to major organ system infections has been poorly defined. A systematic review …